Deciphering breast cancer: from biology to the clinic

E Nolan, GJ Lindeman, JE Visvader - Cell, 2023 - cell.com
Breast cancer remains a leading cause of cancer-related mortality in women, reflecting
profound disease heterogeneity, metastasis, and therapeutic resistance. Over the last …

Targeting senescence as an anticancer therapy

L Bousset, J Gil - Molecular Oncology, 2022 - Wiley Online Library
Cellular senescence is a stress response elicited by different molecular insults. Senescence
results in cell cycle exit and is characterised by multiple phenotypic changes such as the …

Cryo-shocked tumor cells deliver CRISPR-Cas9 for lung cancer regression by synthetic lethality

F Liu, M Xin, H Feng, W Zhang, Z Liao, T Sheng… - Science …, 2024 - science.org
Although CRISPR-mediated genome editing holds promise for cancer therapy, inadequate
tumor targeting and potential off-target side effects hamper its outcomes. In this study, we …

Deciphering signaling pathway interplay via miRNAs in malignant pleural mesothelioma

A Salman, SSA Mageed, D Fathi, MA Elrebehy… - … -Research and Practice, 2023 - Elsevier
Malignant pleural mesothelioma (MPM) is a highly invasive form of lung cancer that
adversely affects the pleural and other linings of the lungs. MPM is a very aggressive tumor …

[PDF][PDF] CDK4/6 inhibitor-mediated cell overgrowth triggers osmotic and replication stress to promote senescence

L Crozier, R Foy, R Adib, A Kar, JA Holt, AU Pareri… - Molecular Cell, 2023 - cell.com
Abnormal increases in cell size are associated with senescence and cell cycle exit. The
mechanisms by which overgrowth primes cells to withdraw from the cell cycle remain …

Targeting sex steroid biosynthesis for breast and prostate cancer therapy

M Poutanen, M Hagberg Thulin, P Härkönen - Nature Reviews Cancer, 2023 - nature.com
Sex steroids are major promoters of the growth of breast and prostate cancers. This Review
by Poutanen et al. describes the development of treatments for these cancer types that act to …

Binding selectivity-dependent molecular mechanism of inhibitors towards CDK2 and CDK6 investigated by multiple short molecular dynamics and free energy …

L Wang, D Lu, Y Wang, X Xu, P Zhong… - Journal of Enzyme …, 2023 - Taylor & Francis
Understanding selectivity-dependent molecular mechanism of inhibitors towards CDK2 over
CDK6 is prominent for improving drug design towards the CDK family. Multiple short …

Sleeping Beauty transposon mutagenesis identified genes and pathways involved in inflammation-associated colon tumor development

K Shimomura, N Hattori, N Iida, Y Muranaka… - Nature …, 2023 - nature.com
Chronic inflammation promotes development and progression of colorectal cancer (CRC).
To comprehensively understand the molecular mechanisms underlying the development …

INX-315, a selective CDK2 inhibitor, induces cell cycle arrest and senescence in solid tumors

C Dietrich, A Trub, A Ahn, M Taylor, K Ambani… - Cancer Discovery, 2024 - AACR
Abstract Cyclin-dependent kinase 2 (CDK2) is thought to play an important role in driving
proliferation of certain cancers, including those harboring CCNE1 amplification and breast …

Immunomodulatory effects of CDK4/6 inhibitors

S Zhang, Q Xu, W Sun, J Zhou, J Zhou - Biochimica et Biophysica Acta …, 2023 - Elsevier
The dysregulation of the cell cycle is one of the hallmarks of cancer. Cyclin-dependent
kinase 4 (CDK4) and CDK6 play crucial roles in regulating cell cycle and other cellular …